Arjo AB (publ) (STO:ARJO.B)
Sweden · Delayed Price · Currency is SEK 24.62
-0.46 (-1.83%)
May 28, 2026, 3:47 PM CET
Arjo AB Market Cap
Arjo AB has a market cap or net worth of 6.7 billion as of May 28, 2026. Its market cap has decreased by -19.77% in one year.
Market Cap
6.70B
Enterprise Value
11.18B
Revenue
10.84B
Ranking
n/a
PE Ratio
19.09
Stock Price
24.62
Market Cap Chart
Since December 12, 2017, Arjo AB's market cap has decreased from 6.71B to 6.70B, a decrease of -0.12%. That is a compound annual growth rate of -0.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 6.83B | -21.67% |
| Dec 30, 2025 | 8.72B | -11.69% |
| Dec 30, 2024 | 9.88B | -7.97% |
| Dec 29, 2023 | 10.73B | 1.18% |
| Dec 30, 2022 | 10.61B | -64.86% |
| Dec 30, 2021 | 30.18B | 76.29% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 153.56B |
| Sectra AB | 53.02B |
| Getinge AB | 52.32B |
| Asker Healthcare Group AB | 32.25B |
| Ambea AB | 12.06B |
| Xvivo Perfusion AB | 9.08B |
| Dynavox Group AB | 8.55B |
| MedCap AB | 8.33B |